Saturday, January 16, 2021
ADVT 
International

Lilly seeks emergency use of its antibody drug for COVID-19

Darpan News Desk The Canadian Press, 07 Oct, 2020
  • Lilly seeks emergency use of its antibody drug for COVID-19

A drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19.

Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Its drug is similar to one that President Donald Trump received on Friday from Regeneron Pharmaceuticals Inc. These medicines supply concentrated versions of specific antibodies to help the immune system clear the coronavirus that causes COVID-19. They’re given as a one-time treatment through an IV.

Lilly has already started making one of the two antibodies in its drug, betting that ongoing studies would prove it worthwhile.

It’s not clear if the evidence will be viewed as strong enough for the Food and Drug Administration to grant emergency use authorization, as it has done for the antiviral drug remdesivir.

The results are an interim look at a mid-stage study in which 112 people received the antibodies and 156 got a placebo.

The amount of virus was significantly lower 11 days later in those given the drug -- the main goal of the study. Virus also was lower at earlier time points as well. Symptom scores were better at three days.

About 5.8% of patients given placebo required hospitalization or an emergency room visit versus 0.9% of those given the antibodies.

The company said there were no serious drug-related side effects.

MORE International ARTICLES

US outlines sweeping plan to provide free COVID-19 vaccines

US outlines sweeping plan to provide free COVID-19 vaccines

Since the poll, questions have only mounted about whether the government is trying to rush treatments and vaccines to help President Donald Trump's reelection chances.

US outlines sweeping plan to provide free COVID-19 vaccines

Seeping under doors, bad air from West's fires won't ease up

Seeping under doors, bad air from West's fires won't ease up

People in Oregon, Washington state and California have been struggling for a week or longer under some of the most unhealthy air on the planet.

Seeping under doors, bad air from West's fires won't ease up

Cyprus police probe tossing of chickens, rabbits at school

Cyprus police probe tossing of chickens, rabbits at school

The high school's principal filed a complaint about the actions involving the rabbits and chickens, and several students have been questioned, the police spokesman said.

Cyprus police probe tossing of chickens, rabbits at school

Pew poll finds Canada's view of U.S. at record low

Pew poll finds Canada's view of U.S. at record low

The finding tracks an identical trend among all 13 countries involved in the poll — record lows were also recorded in the U.K., France, Germany, Japan and Australia.

Pew poll finds Canada's view of U.S. at record low

Macy's plans smaller but camera-ready Thanksgiving parade

Macy's plans smaller but camera-ready Thanksgiving parade

Macy's similarly remade its traditional July Fourth fireworks show this year, swapping the big one-night spectacle for a series of smaller fireworks displays.

Macy's plans smaller but camera-ready Thanksgiving parade

Trump, DeVos raise school choice in appeal to vexed parents

Trump, DeVos raise school choice in appeal to vexed parents

For Trump, it’s seen as a potential lifeline to Black and Hispanic voters, who are more likely to support vouchers and other school choice options, polls have found.

Trump, DeVos raise school choice in appeal to vexed parents